Description
P3.07 Feasibility of analyzing BCR-ABL1 transcripts on bone marrow samples using the GeneXpert system
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: P3.07 Feasibility of analyzing BCR-ABL1 transcripts on bone marrow samples using the GeneXpert system
€2.42
